Zymeworks Inc. Files 8-K Report
Ticker: ZYME · Form: 8-K · Filed: Nov 17, 2025 · CIK: 1937653
Sentiment: neutral
Topics: 8-K, SEC Filing, Financials
TL;DR
Zymeworks filed an 8-K on 11/17/25, mostly for routine financial docs.
AI Summary
On November 17, 2025, Zymeworks Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company is incorporated in Delaware and its principal executive offices are located at 108 Patriot Drive, Suite A, Middletown, DE 19709.
Why It Matters
This 8-K filing indicates Zymeworks Inc. is providing updates or submitting required financial documentation to the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and financial statements, not indicating any immediate material adverse events.
Key Players & Entities
- Zymeworks Inc. (company) — Registrant
- November 17, 2025 (date) — Date of earliest event reported
- Delaware (location) — State of incorporation
- 108 Patriot Drive, Suite A, Middletown, Delaware 19709 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Zymeworks Inc.?
The filing is for 'Other Events' and 'Financial Statements and Exhibits', indicating routine updates or submissions to the SEC.
When was the earliest event reported in this filing?
The earliest event reported is November 17, 2025.
Where are Zymeworks Inc.'s principal executive offices located?
The principal executive offices are located at 108 Patriot Drive, Suite A, Middletown, Delaware 19709.
What is the state of incorporation for Zymeworks Inc.?
Zymeworks Inc. is incorporated in Delaware.
Does this 8-K filing disclose any specific material events or transactions?
Based on the provided text, the filing is categorized under 'Other Events' and 'Financial Statements and Exhibits' without detailing specific material events.
Filing Stats: 468 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2025-11-17 06:13:29
Key Financial Figures
- $0.00001 — ich registered Common Stock, par value $0.00001 per share ZYME The Nasdaq Stock Mar
Filing Documents
- d17392d8k.htm (8-K) — 26KB
- d17392dex991.htm (EX-99.1) — 24KB
- g17392g1117074035430.jpg (GRAPHIC) — 4KB
- 0001193125-25-283873.txt ( ) — 174KB
- zyme-20251117.xsd (EX-101.SCH) — 3KB
- zyme-20251117_lab.xml (EX-101.LAB) — 18KB
- zyme-20251117_pre.xml (EX-101.PRE) — 11KB
- d17392d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated November 17, 2025 104 Cover Page Interactive Data File (embedded as Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ZYMEWORKS INC. (Registrant) Date: November 17, 2025 By: /s/ Kenneth Galbraith Name: Title: Kenneth Galbraith Chair, President and Chief Executive Officer